Literature DB >> 2259880

Follow-up study of ankylosing spondylitis over a period of 12 years (1977-1989).

A J Dekker-Saeys1, A C Keat.   

Abstract

A follow-up study was performed on 256 patients with ankylosing spondylitis. HLA-B27-negative Dutch patients very rarely had classical idiopathic ankylosing spondylitis. Most of these patients had psoriasis or inflammatory bowel disease or they were foreigners living in The Netherlands. Many of the B27-negative patients only have sacroiliitis. Psoriasis or inflammatory bowel disease among the HLA-B27-positive with a classical ankylosing spondylitis is rare.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2259880     DOI: 10.3109/03009749009097071

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  5 in total

1.  Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.

Authors:  J Capkova; P Ivanyi; Z Rehakova
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

2.  Evaluation of the incidence of haemorrhoidal disease in patients with ankylosing spondylitis.

Authors:  Mehmet Caglayan; Ahmet Türkoğlu; Pelin Oktayoglu; Mehmet Yıldız; Abdullah Zübeyir Dağlı; Abdullah Böyük; Serda Em; Mehtap Bozkurt; Kemal Nas
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

3.  Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 4.  Ankylosing spondylitis, IgA, and transforming growth factors.

Authors:  J R Archer
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

Review 5.  Genetics of spondyloarthritis--beyond the MHC.

Authors:  John D Reveille
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.